These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1059 related items for PubMed ID: 20399203

  • 21. Copper imbalance and oxidative stress in neurodegeneration.
    Rossi L, Arciello M, Capo C, Rotilio G.
    Ital J Biochem; 2006; 55(3-4):212-21. PubMed ID: 17274527
    [Abstract] [Full Text] [Related]

  • 22. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
    Tan L, Yu JT, Tan L.
    J Neurol Sci; 2012 Dec 15; 323(1-2):1-8. PubMed ID: 22939820
    [Abstract] [Full Text] [Related]

  • 23. Elevated levels of ferrimagnetic metals in foodchains supporting the Guam cluster of neurodegeneration: do metal nucleated crystal contaminants [corrected] evoke magnetic fields that initiate the progressive pathogenesis of neurodegeneration?
    Purdey M.
    Med Hypotheses; 2004 Dec 15; 63(5):793-809. PubMed ID: 15488650
    [Abstract] [Full Text] [Related]

  • 24. Metals in Alzheimer's and Parkinson's diseases.
    Barnham KJ, Bush AI.
    Curr Opin Chem Biol; 2008 Apr 15; 12(2):222-8. PubMed ID: 18342639
    [Abstract] [Full Text] [Related]

  • 25. Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases.
    Wilhelmus MM, van Dam AM, Drukarch B.
    Eur J Pharmacol; 2008 May 13; 585(2-3):464-72. PubMed ID: 18417122
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
    Chen JF, Chern Y.
    Handb Exp Pharmacol; 2011 May 13; (200):267-310. PubMed ID: 20859800
    [Abstract] [Full Text] [Related]

  • 28. Targeting programmed cell death in neurodegenerative diseases.
    Vila M, Przedborski S.
    Nat Rev Neurosci; 2003 May 13; 4(5):365-75. PubMed ID: 12728264
    [No Abstract] [Full Text] [Related]

  • 29. Metal attenuating therapies in neurodegenerative disease.
    Mot AI, Wedd AG, Sinclair L, Brown DR, Collins SJ, Brazier MW.
    Expert Rev Neurother; 2011 Dec 13; 11(12):1717-45. PubMed ID: 22091597
    [Abstract] [Full Text] [Related]

  • 30. Iron: a new target for pharmacological intervention in neurodegenerative diseases.
    Whitnall M, Richardson DR.
    Semin Pediatr Neurol; 2006 Sep 13; 13(3):186-97. PubMed ID: 17101458
    [Abstract] [Full Text] [Related]

  • 31. Free radical damage and oxidative stress in Huntington's disease.
    Borlongan CV, Kanning K, Poulos SG, Freeman TB, Cahill DW, Sanberg PR.
    J Fla Med Assoc; 1996 May 13; 83(5):335-41. PubMed ID: 8666972
    [Abstract] [Full Text] [Related]

  • 32. Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function.
    Teixeira AL, Barbosa IG, Diniz BS, Kummer A.
    Biomark Med; 2010 Dec 13; 4(6):871-87. PubMed ID: 21133708
    [Abstract] [Full Text] [Related]

  • 33. Multi-target-directed ligands to combat neurodegenerative diseases.
    Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, Recanatini M, Melchiorre C.
    J Med Chem; 2008 Feb 14; 51(3):347-72. PubMed ID: 18181565
    [No Abstract] [Full Text] [Related]

  • 34. Metals ions and neurodegeneration.
    Molina-Holgado F, Hider RC, Gaeta A, Williams R, Francis P.
    Biometals; 2007 Jun 14; 20(3-4):639-54. PubMed ID: 17294125
    [Abstract] [Full Text] [Related]

  • 35. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview.
    Mariani E, Polidori MC, Cherubini A, Mecocci P.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov 15; 827(1):65-75. PubMed ID: 16183338
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Mitochondrial dysfunction in neurodegenerative diseases and cancer.
    de Moura MB, dos Santos LS, Van Houten B.
    Environ Mol Mutagen; 2010 Jun 15; 51(5):391-405. PubMed ID: 20544881
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 53.